ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 3.430
-0.210 (-5.77%)
Sep 29, 2025, 11:44 AM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €126.22 million as of September 29, 2025. Its market cap has increased by 191.20% in one year.
Market Cap
126.22M
Enterprise Value
125.75M
Revenue
4.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.43
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 126.22M, a decrease of -41.06%. That is a compound annual growth rate of -4.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 126.22M | 205.88% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | 24.29M | 229.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.29B |
| Sanofi | 95.30B |
| Sartorius Stedim Biotech | 16.69B |
| bioMérieux | 13.34B |
| Eurofins Scientific SE | 10.82B |
| Ipsen | 9.19B |
| ABIVAX Société Anonyme | 5.31B |
| Virbac | 2.63B |